Europe Hepatitis A Vaccine Market Report 2016

Publisher Name :
Date: 09-Dec-2016
No. of pages: 102
Inquire Before Buying

Notes:

Sales, means the sales volume of Hepatitis A Vaccine

Revenue, means the sales value of Hepatitis A Vaccine

This report studies sales (consumption) of Hepatitis A Vaccine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- GlaxoSmithKline

- MERCK SHARP & DOHME CORP

- SANOFI PASTEUR

- NORVATIS

- CRUCELL

- ...

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Hepatitis A Vaccine in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Hepatitis A Vaccine in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Hepatitis A Vaccine Market Report 2016

Table of Contents
Europe Hepatitis A Vaccine Market Report 2016
1 Hepatitis A Vaccine Overview
1.1 Product Overview and Scope of Hepatitis A Vaccine
1.2 Classification of Hepatitis A Vaccine
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Hepatitis A Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Hepatitis A Vaccine Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Hepatitis A Vaccine (2011-2021)
1.5.1 Europe Hepatitis A Vaccine Sales and Growth Rate (2011-2021)
1.5.2 Europe Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
2 Europe Hepatitis A Vaccine by Manufacturers, Type and Application
2.1 Europe Hepatitis A Vaccine Market Competition by Manufacturers
2.1.1 Europe Hepatitis A Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Hepatitis A Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Hepatitis A Vaccine (Volume and Value) by Type
2.2.1 Europe Hepatitis A Vaccine Sales and Market Share by Type (2011-2016)
2.2.2 Europe Hepatitis A Vaccine Revenue and Market Share by Type (2011-2016)
2.3 Europe Hepatitis A Vaccine (Volume and Value) by Countries
2.3.1 Europe Hepatitis A Vaccine Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Hepatitis A Vaccine Revenue and Market Share by Countries (2011-2016)
2.4 Europe Hepatitis A Vaccine (Volume) by Application
3 Germany Hepatitis A Vaccine (Volume, Value and Sales Price)
3.1 Germany Hepatitis A Vaccine Sales and Value (2011-2016)
3.1.1 Germany Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
3.1.2 Germany Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
3.1.3 Germany Hepatitis A Vaccine Sales Price Trend (2011-2016)
3.2 Germany Hepatitis A Vaccine Sales and Market Share by Manufacturers
3.3 Germany Hepatitis A Vaccine Sales and Market Share by Type
3.4 Germany Hepatitis A Vaccine Sales and Market Share by Application
4 France Hepatitis A Vaccine (Volume, Value and Sales Price)
4.1 France Hepatitis A Vaccine Sales and Value (2011-2016)
4.1.1 France Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
4.1.2 France Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
4.1.4 France Hepatitis A Vaccine Sales Price Trend (2011-2016)
4.2 France Hepatitis A Vaccine Sales and Market Share by Manufacturers
4.3 France Hepatitis A Vaccine Sales and Market Share by Type
4.4 France Hepatitis A Vaccine Sales and Market Share by Application
5 UK Hepatitis A Vaccine (Volume, Value and Sales Price)
5.1 UK Hepatitis A Vaccine Sales and Value (2011-2016)
5.1.1 UK Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
5.1.2 UK Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
5.1.5 UK Hepatitis A Vaccine Sales Price Trend (2011-2016)
5.2 UK Hepatitis A Vaccine Sales and Market Share by Manufacturers
5.3 UK Hepatitis A Vaccine Sales and Market Share by Type
5.4 UK Hepatitis A Vaccine Sales and Market Share by Application
6 Russia Hepatitis A Vaccine (Volume, Value and Sales Price)
6.1 Russia Hepatitis A Vaccine Sales and Value (2011-2016)
6.1.1 Russia Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
6.1.2 Russia Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
6.1.6 Russia Hepatitis A Vaccine Sales Price Trend (2011-2016)
6.2 Russia Hepatitis A Vaccine Sales and Market Share by Manufacturers
6.3 Russia Hepatitis A Vaccine Sales and Market Share by Type
6.4 Russia Hepatitis A Vaccine Sales and Market Share by Application
7 Italy Hepatitis A Vaccine (Volume, Value and Sales Price)
7.1 Italy Hepatitis A Vaccine Sales and Value (2011-2016)
7.1.1 Italy Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
7.1.2 Italy Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
7.1.7 Italy Hepatitis A Vaccine Sales Price Trend (2011-2016)
7.2 Italy Hepatitis A Vaccine Sales and Market Share by Manufacturers
7.3 Italy Hepatitis A Vaccine Sales and Market Share by Type
7.4 Italy Hepatitis A Vaccine Sales and Market Share by Application
8 Spain Hepatitis A Vaccine (Volume, Value and Sales Price)
8.1 Spain Hepatitis A Vaccine Sales and Value (2011-2016)
8.1.1 Spain Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
8.1.2 Spain Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
8.1.8 Spain Hepatitis A Vaccine Sales Price Trend (2011-2016)
8.2 Spain Hepatitis A Vaccine Sales and Market Share by Manufacturers
8.3 Spain Hepatitis A Vaccine Sales and Market Share by Type
8.4 Spain Hepatitis A Vaccine Sales and Market Share by Application
9 Benelux Hepatitis A Vaccine (Volume, Value and Sales Price)
9.1 Benelux Hepatitis A Vaccine Sales and Value (2011-2016)
9.1.1 Benelux Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
9.1.2 Benelux Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Hepatitis A Vaccine Sales Price Trend (2011-2016)
9.2 Benelux Hepatitis A Vaccine Sales and Market Share by Manufacturers
9.3 Benelux Hepatitis A Vaccine Sales and Market Share by Type
9.4 Benelux Hepatitis A Vaccine Sales and Market Share by Application
10 Europe Hepatitis A Vaccine Manufacturers Analysis
10.1 GlaxoSmithKline
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Hepatitis A Vaccine Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 GlaxoSmithKline Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 MERCK SHARP & DOHME CORP
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Hepatitis A Vaccine Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 MERCK SHARP & DOHME CORP Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 SANOFI PASTEUR
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Hepatitis A Vaccine Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 SANOFI PASTEUR Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 NORVATIS
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Hepatitis A Vaccine Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 NORVATIS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 CRUCELL
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Hepatitis A Vaccine Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 CRUCELL Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
...
11 Hepatitis A Vaccine Manufacturing Cost Analysis
11.1 Hepatitis A Vaccine Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Hepatitis A Vaccine
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Hepatitis A Vaccine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Hepatitis A Vaccine Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Hepatitis A Vaccine Market Forecast (2016-2021)
14.1 Germany Hepatitis A Vaccine Sales Forecast (2016-2021)
14.2 France Hepatitis A Vaccine Sales Forecast (2016-2021)
14.3 UK Hepatitis A Vaccine Sales Forecast (2016-2021)
14.4 Russia Hepatitis A Vaccine Sales Forecast (2016-2021)
14.5 Italy Hepatitis A Vaccine Sales Forecast (2016-2021)
14.6 Spain Hepatitis A Vaccine Sales Forecast (2016-2021)
14.7 Benelux Hepatitis A Vaccine Sales Forecast (2016-2021)
14.8 Europe Hepatitis A Vaccine Sales Forecast by Type (2016-2021)
14.9 Europe Hepatitis A Vaccine Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Hepatitis A Vaccine
Table Classification of Hepatitis A Vaccine
Figure Europe Sales Market Share of Hepatitis A Vaccine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Hepatitis A Vaccine
Figure Europe Sales Market Share of Hepatitis A Vaccine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure France Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure UK Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Russia Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Italy Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Spain Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Benelux Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Figure Europe Hepatitis A Vaccine Sales and Growth Rate (2011-2021)
Figure Europe Hepatitis A Vaccine Revenue and Growth Rate (2011-2021)
Table Europe Hepatitis A Vaccine Sales of Key Manufacturers (2015 and 2016)
Table Europe Hepatitis A Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hepatitis A Vaccine Sales Share by Manufacturers
Figure 2016 Hepatitis A Vaccine Sales Share by Manufacturers
Table Europe Hepatitis A Vaccine Revenue by Manufacturers (2015 and 2016)
Table Europe Hepatitis A Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Hepatitis A Vaccine Revenue Share by Manufacturers
Table 2016 Europe Hepatitis A Vaccine Revenue Share by Manufacturers
Table Europe Hepatitis A Vaccine Sales and Market Share by Type (2011-2016)
Table Europe Hepatitis A Vaccine Sales Share by Type (2011-2016)
Figure Sales Market Share of Hepatitis A Vaccine by Type (2011-2016)
Figure Europe Hepatitis A Vaccine Sales Growth Rate by Type (2011-2016)
Table Europe Hepatitis A Vaccine Revenue and Market Share by Type (2011-2016)
Table Europe Hepatitis A Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Hepatitis A Vaccine by Type (2011-2016)
Figure Europe Hepatitis A Vaccine Revenue Growth Rate by Type (2011-2016)
Table Europe Hepatitis A Vaccine Sales and Market Share by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Sales Share by Countries (2011-2016)
Figure Sales Market Share of Hepatitis A Vaccine by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Revenue and Market Share by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Hepatitis A Vaccine by Countries (2011-2016)
Table Europe Hepatitis A Vaccine Sales and Market Share by Application (2011-2016)
Table Europe Hepatitis A Vaccine Sales Share by Application (2011-2016)
Figure Sales Market Share of Hepatitis A Vaccine by Application (2011-2016)
Figure Germany Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Germany Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Germany Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Germany Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Germany Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Germany Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Germany Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Germany Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Germany Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure France Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure France Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure France Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table France Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table France Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table France Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table France Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table France Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table France Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure UK Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure UK Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure UK Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table UK Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table UK Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table UK Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table UK Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table UK Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table UK Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Russia Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Russia Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Russia Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Russia Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Russia Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Russia Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Russia Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Russia Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Russia Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Italy Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Italy Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Italy Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Italy Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Italy Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Italy Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Italy Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Italy Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Italy Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Spain Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Spain Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Spain Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Spain Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Spain Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Spain Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Spain Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Spain Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Spain Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Figure Benelux Hepatitis A Vaccine Sales and Growth Rate (2011-2016)
Figure Benelux Hepatitis A Vaccine Revenue and Growth Rate (2011-2016)
Figure Benelux Hepatitis A Vaccine Sales Price Trend (2011-2016)
Table Benelux Hepatitis A Vaccine Sales by Manufacturers (2015 and 2016)
Table Benelux Hepatitis A Vaccine Market Share by Manufacturers (2015 and 2016)
Table Benelux Hepatitis A Vaccine Sales by Type (2015 and 2016)
Table Benelux Hepatitis A Vaccine Market Share by Type (2015 and 2016)
Table Benelux Hepatitis A Vaccine Sales by Application (2015 and 2016)
Table Benelux Hepatitis A Vaccine Market Share by Application (2015 and 2016)
Table Hepatitis A Vaccine Basic Information List
Table GlaxoSmithKline Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Hepatitis A Vaccine Sales Market Share (2011-2016)
Table MERCK SHARP & DOHME CORP Basic Information List
Table MERCK SHARP & DOHME CORP Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table MERCK SHARP & DOHME CORP Hepatitis A Vaccine Sales Market Share (2011-2016)
Table SANOFI PASTEUR Basic Information List
Table SANOFI PASTEUR Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table SANOFI PASTEUR Hepatitis A Vaccine Sales Market Share (2011-2016)
Table NORVATIS Basic Information List
Table NORVATIS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table NORVATIS Hepatitis A Vaccine Sales Market Share (2011-2016)
Table CRUCELL Basic Information List
Table CRUCELL Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CRUCELL Hepatitis A Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis A Vaccine
Figure Manufacturing Process Analysis of Hepatitis A Vaccine
Figure Hepatitis A Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis A Vaccine Major Manufacturers in 2015
Table Major Buyers of Hepatitis A Vaccine
Table Distributors/Traders List
Figure Germany Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Germany Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure France Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure France Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure UK Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure UK Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Russia Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Italy Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Spain Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Hepatitis A Vaccine Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Hepatitis A Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table Europe Hepatitis A Vaccine Sales Forecast by Type (2016-2021)
Table Europe Hepatitis A Vaccine Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Hepatitis D - Pipeline Review, H1 2017
    Published: 16-May-2017        Price: US 2000 Onwards        Pages: 71
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H1 2017, provides an overview of the Hepatitis D (Infectious Disease) pipeline landscape.Hepatitis D, also known as the delta virus, is an infection that causes liver to swell. It is caused by the hepatitis D virus (HDV). Symptoms include yellowing of skin and eyes, joint pain, abdominal pains, vomiting, loss of appetite and fatigue. Risk factors include receiving many blood tran......
  • Hepatitis A - Pipeline Review, H1 2017
    Published: 16-May-2017        Price: US 2000 Onwards        Pages: 25
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Pipeline Review, H1 2017, provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape.Hepatitis A is inflammation of the liver caused by hepatitis A virus. Symptoms include fatigue, nausea and vomiting, inflammation of the liver, loss of appetite, dark urine, muscle pain and yellowing of the skin and eyes (jaundice). Risk factors include weakened immune system and use injected......
  • Hepatitis C - Pipeline Review, H1 2017
    Published: 28-Apr-2017        Price: US 2000 Onwards        Pages: 443
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, H1 2017, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape. Hepatitis C is a contagious viral infection affecting the liver. It may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jau......
  • Global Hepatitis A Vaccine Sales Market Report 2017
    Published: 26-Apr-2017        Price: US 4000 Onwards        Pages: 112
    In this report, the global Hepatitis A Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Alcoholic Hepatitis - Pipeline Review, H1 2017
    Published: 11-Apr-2017        Price: US 2000 Onwards        Pages: 58
    Alcoholic Hepatitis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcoholic Hepatitis - Pipeline Review, H1 2017, provides an overview of the Alcoholic Hepatitis (Gastrointestinal) pipeline landscape. Alcoholic hepatitis is an inflammation of the liver. It is typically caused by excessive alcohol consumption over a long period of time. Symptoms include changes in appetite, dry mout......
  • Global Hepatitis Partnering 2010 to 2017
    Published: 01-Apr-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Hepatitis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value......
  • Global Sofosbuvir Market Research Report 2017
    Published: 30-Mar-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Sofosbuvir market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sofosbuvir in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • Global Human Hepatitis B Immunoglobulin (IM) Sales Market Report 2017
    Published: 30-Mar-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the global Human Hepatitis B Immunoglobulin (IM) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Human Hepatitis B Immunoglobulin (IM) for these regions, from 2012 to 2022 (forecast), covering - United States - Ch......
  • United States Hepatitis Drugs Market Report 2017
    Published: 10-Jan-2017        Price: US 3800 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies sales (consumption) of Hepatitis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - F. Hoffmann-La Roche - Gilead Sciences - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - Vertex Pharmaceuticals - Ab......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs